New Co-Author Publication in Gut: CDK4 inhibitors for treatment of Pancreatic Cancer

More great news, we have another co-author publication in the outstanding journal Gut. This fabulous work was pioneered by the very talented Dr Marina Pajic and her group at the Garvan Institute. We were very honoured to be involved in such amazing work. The title of the publication is “Tailored first-line and second-line CDK4-targeting treatment […]

Read More New Co-Author Publication in Gut: CDK4 inhibitors for treatment of Pancreatic Cancer

New Co-Author Publication! Ensa controls S-phase length by modulating Treslin levels.

Great news, we have published a co-authored paper entitled ‘Ensa controls S-phase length by modulating Treslin levels’ in the prestigious journal ‘Nature Communications’. This work was started back in 2011 when I was a Post-Doc in the laboratory of Anna Castro in France. It’s exciting to see those inital discoveries transition into the finished paper. The […]

Read More New Co-Author Publication! Ensa controls S-phase length by modulating Treslin levels.

New Publication in Cell! The Phosphoregulation of Mitosis

We are incredibly excited to announce that our SnapShot is out today in Cell! This snapshot of mitosis collates hundreds of phosphorylation events and directly links them with their regulatory kinases and counterbalancing phosphatases, in both time and space, in a highly innovative ‘circtanglar’ cell layout. More importantly, the static PDF version is accompanied by an […]

Read More New Publication in Cell! The Phosphoregulation of Mitosis

8th Garvan Signalling Symposium – Registration Now Open !!!

8th Garvan Signalling Symposium  Date: Monday 31st of October and Tuesday 1st of November 2016 Venue: The Garvan Institute of Medical Research, Sydney Registration – Abstract submission to 15th of September 2016  The Garvan International Signalling Symposium is a premier meeting focused on the mechanisms of signal transduction. It began as a small meeting organised by […]

Read More 8th Garvan Signalling Symposium – Registration Now Open !!!

Switching off Cancers Diversity

A defining feature in over 2/3rds of all solid tumours is the continual loss and gain of whole are small parts of chromosomes. This instability, or CIN for short, strongly implicated in tumour initiation, progression, chemoresistance and poor prognosis. CIN is created through failures during mitosis, whereby whole or parts of a chromosome are segregated […]

Read More Switching off Cancers Diversity

New Publication: Clinical Overview of MDM2/X-Targeted Therapies

Great news, we have a new Mini-Review published in Frontiers Oncology entitled “Clinical Overview of MDM2/X-Targeted Therapies“, which is apart of the Research Topic Human tumor-derived p53 mutants: a growing family of oncoproteins Here is a little snippet from the Abstract to wet your appetite! MDM2 and MDMX are the primary negative regulators of p53, which under […]

Read More New Publication: Clinical Overview of MDM2/X-Targeted Therapies

New Review Article Published!! “Mechanisms Regulating Phosphatase Specificity During Mitotic Exit”

Great News, we have a new review article that has just been published online today in Inside the Cell! Its Open Access, so that means its free for everyone to read! During mitotic exit, phosphatases reverse thousands of phosphorylation events in a specific temporal order to ensure that cell division occurs correctly. This review explores how […]

Read More New Review Article Published!! “Mechanisms Regulating Phosphatase Specificity During Mitotic Exit”